High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial (pages 1194–1203)Philip J. Clements, Daniel E. Furst, Weng-Kee Wong, Maureen Mayes, Barbara White, Fredrick Wigley, Michael H. Weisman, Walter Barr, Larry W. Moreland, Thomas A. Medsger Jr., Virginia Steen, Richard W. Martin, David Collier, Arthur Weinstein, Edward Lally, John Varga, Steven Weiner, Brian Andrews, Micha Abeles and James R. Seibold
Article first published online: 26 APR 2001 | DOI: 10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7